Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node‑Positive Breast Cancer Por [email protected] Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node‑Positive Breast Cancer Read More »
Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers Por [email protected] Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers Read More »
Immediate reconstruction with implant post-mastectomy with prepectoral versus submuscular technique: experience of a public oncological treatment center Por [email protected] Immediate reconstruction with implant post-mastectomy with prepectoral versus submuscular technique: experience of a public oncological treatment center Read More »
Aerobic exercise and Cognitive functioning in women with breast cancer (ACTIVATE): A randomized controlled trial Por [email protected] Aerobic exercise and Cognitive functioning in women with breast cancer (ACTIVATE): A randomized controlled trial Read More »
Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy Results from the I‑SPY2 Clinical Trial Por [email protected] Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy Results from the I‑SPY2 Clinical Trial Read More »
Immediate breast reconstruction by prepectoral polyurethane implant: Preliminary results of the prospective study PreQ-20 Por [email protected] Immediate breast reconstruction by prepectoral polyurethane implant: Preliminary results of the prospective study PreQ-20 Read More »
Significantly reducing implant loss rates in immediate implant-based breast reconstruction: A protocol and completed audit of quality assurance Por [email protected] Significantly reducing implant loss rates in immediate implant-based breast reconstruction: A protocol and completed audit of quality assurance Read More »
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy Por [email protected] TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy Read More »
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2 Por [email protected] Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2 Read More »
FDA approves inavolisib with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer Por [email protected] FDA approves inavolisib with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer Read More »
Differential prognostic value of residual nodal burden in breast cancer subtypes Por [email protected] Differential prognostic value of residual nodal burden in breast cancer subtypes Read More »
A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B) Por [email protected] A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B) Read More »
